Evidence map›Paper›PMID 39870638›Full record

ArticleScientific data2025

PCMMD: A Novel Dataset of Plasma Cells to Support the Diagnosis of Multiple Myeloma.

Caio L B Andrade, Marcos V Ferreira, Brenno M Alencar, Jorge L S B Filho, Matheus A Guimaraes, Iarley Porto Cruz Moraes, Tiago J S Lopes, Allan S Dos Santos, Mariane M Dos Santos, Maria I C S E Silva and 9 more

Abstract readDataset
In one paragraph

Article in Scientific data, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Caio L B AndradeFederal University of Bahia, Institute of Computing, Salvador, 40170-110, Brazil.
Marcos V FerreiraFederal University of Bahia, Institute of Computing, Salvador, 40170-110, Brazil.
Brenno M AlencarFederal University of Bahia, Institute of Computing, Salvador, 40170-110, Brazil.
Jorge L S B FilhoFederal University of Bahia, Institute of Computing, Salvador, 40170-110, Brazil.
Matheus A GuimaraesFederal University of Bahia, Institute of Computing, Salvador, 40170-110, Brazil.
Iarley Porto Cruz MoraesFederal University of Bahia, Institute of Computing, Salvador, 40170-110, Brazil.
Tiago J S LopesNezu Biotech GmbH, Heidelberg, 69121, Germany.
Allan S Dos SantosFederal University of Bahia, Institute of Health Sciences, Salvador, 40231-300, Brazil.
Mariane M Dos SantosFederal University of Bahia, Institute of Health Sciences, Salvador, 40231-300, Brazil.
Maria I C S E SilvaFederal University of Bahia, Institute of Health Sciences, Salvador, 40231-300, Brazil.
Izabela M D R P RosaFederal University of Bahia, Institute of Health Sciences, Salvador, 40231-300, Brazil.
Gilson C de CarvalhoFederal University of Bahia, Institute of Health Sciences, Salvador, 40231-300, Brazil.
Herbert H M SantosFederal University of Bahia, Institute of Health Sciences, Salvador, 40231-300, Brazil.
Márcia M L SantosFederal University of Bahia, Hospital Universitario Professor Edgard Santos - HUPES, Salvador, 40110-060, Brazil.
Roberto MeyerFederal University of Bahia, Institute of Health Sciences, Salvador, 40231-300, Brazil.
Luciana M P B KnopHospital Martagão Gesteira, LABCMI-HMG, Salvador, 40050-050, Brazil.
Songeli M FreireFederal University of Bahia, Institute of Health Sciences, Salvador, 40231-300, Brazil.
Ricardo A RiosFederal University of Bahia, Institute of Computing, Salvador, 40170-110, Brazil. ricardoar@ufba.br.ORCID http://orcid.org/0000-0003-1449-4745
Tatiane N RiosFederal University of Bahia, Institute of Computing, Salvador, 40170-110, Brazil.

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Brazilian Federal Agency for the Support and Evaluation of Graduate Education) 001Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Brazilian Federal Agency for the Support and Evaluation of Graduate Education) N/ACouncil for Science, Technology and Innovation (CSTI) N/AFundação de Amparo à Pesquisa do Estado da Bahia (Foundation for Research Support of the State of Bahia) 1589/2021Fundação de Amparo à Pesquisa do Estado da Bahia (Foundation for Research Support of the State of Bahia) PIE0002/2022MEXT | Japan Society for the Promotion of Science (JSPS) JP22K06119Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Científico e Tecnológico (National Council for Scientific and Technological Development) 312755/2023-6Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Científico e Tecnológico (National Council for Scientific and Technological Development) 313053/2023-5Morinaga Foundation For Health and Nutrition SIPAIH20D01National Center for Child Health and Development (NCCHD) 2022B-2Terumo Foundation for Life Sciences and Arts 406354/2023-5
6 · The paper itself

Abstract

Multiple Myeloma (MM) is a cytogenetically heterogeneous clonal plasma cell proliferative disease whose diagnosis is supported by analyses on histological slides of bone marrow aspirate. In summary, experts use a labor-intensive methodology to compute the ratio between plasma cells and non-plasma cells. Therefore, the key aspect of the methodology is identifying these cells, which relies on the experts' attention and experience. In this work, we present a valuable dataset comprising more than 5,000 plasma and non-plasma cells, labeled by experts, along with some patient diagnostics. We also share a Deep Neural Network model, as a benchmark, trained to identify and count plasma and non-plasma cells automatically. The contributions of this work are two-fold: (i) the labeled cells can be used to train new practitioners and support continuing medical education; and (ii) the design of new methods to identify such cells, improving the results presented by our benchmark. We emphasize that our work supports the diagnosis of MM in practical scenarios and paves new ways to advance the state-of-the-art.

Indexed as

Multiple MyelomaPlasma CellsHumansNeural Networks, Computer

Identifiers

PMID39870638
PMCPMC11772599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.